Mergers & AcquisitionsMedium•16 November 2026•
1 min read
Sun Pharma Seeks $4 Billion Loan to Refinance Organon Acquisition Debt
Key Facts
1Sun Pharma is in talks for a $4 billion loan to refinance debt related to its acquisition of Organon.
Sun Pharma is in talks for a $4 billion loan to refinance debt related to its acquisition of Organon. Investing.com reported that the company is seeking the funds from a consortium of banks to refinance existing debt obligations incurred during the acquisition process.
The company aims to optimize its capital structure and manage the financing costs of the Organon acquisition through this refinancing. Regarding related equity performance, Organon shares, trading under the ticker OGN, closed at $13.9 on November 13, 2026.